Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Curis, Inc.
Curis, Inc.
Artios Pharma Ltd
Ensem Therapeutics
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
AstraZeneca
EMD Serono
EMD Serono
AstraZeneca
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
University of Pittsburgh
Memorial Sloan Kettering Cancer Center
Novartis
Acrivon Therapeutics
Revolution Medicines, Inc.
Pharmassist Ltd
Faeth Therapeutics
Kura Oncology, Inc.
AstraZeneca
Novartis
Johns Hopkins University
National University Hospital, Singapore
AstraZeneca
Hangzhou Polymed Biopharmaceuticals, Inc.
Johns Hopkins University
Totus Medicines
AstraZeneca
Simons Searchlight
Sanford Health
Swiss Cancer Institute
Revolution Medicines, Inc.
Minia University
Assistance Publique - Hôpitaux de Paris
Incyte Corporation
Case Comprehensive Cancer Center
Zhuhai Yufan Biotechnologies Co., Ltd
Merck KGaA, Darmstadt, Germany
Nimbus Therapeutics
Actuate Therapeutics Inc.
Pfizer
Novartis
EMD Serono
Novartis
Regor Pharmaceuticals Inc.
Aadi Bioscience, Inc.
Incyte Corporation
Bayer
Haihe Biopharma Co., Ltd.
Massachusetts General Hospital
Pfizer